user

ERWINIA ASPARAGINASE USE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA ALLERGIC TO PEGASPARGASE

被引：0
|
作者：
van Rijswijk, E. [1 ]
Mycroft, J. [2 ]
机构：
[1] Royal Marsden Hosp, Paediat Haematol & Oncol, Sutton, Surrey, England
[2] Royal Marsden Hosp, Pharm, Sutton, Surrey, England
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-085
引用
收藏
页码：S261 / S261
页数：1
相关论文
共 50 条
  • [41] PEGylated E. coli asparaginase desensitization: an effective and feasible option for pediatric patients with acute lymphoblastic leukemia who have developed hypersensitivity to pegaspargase in the absence of asparaginase Erwinia chrysanthemi availability
    Verma, Anupam
    Chen, Karin
    Bender, Cynthia
    Gorney, Nathan
    Leonard, Whitney
    Barnette, Phillip
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2019, 36 (05) : 277 - 286
  • [42] Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients
    Sassen, Sebastiaan D. T.
    Mathot, Ron A. A.
    Pieters, Rob
    Kloos, Robin Q. H.
    de Haas, Valerie
    Kaspers, Gertjan J. L.
    van den Bos, Cor
    Tissing, Wim J. E.
    te Loo, Maroeska
    Bierings, Marc B.
    Kollen, Wouter J. W.
    Zwaan, Christian M.
    van der Sluis, Inge M.
    HAEMATOLOGICA, 2017, 102 (03) : 552 - 561
  • [43] Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    Maese, Luke
    Rau, Rachel E.
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [44] Asparaginase use for the treatment of acute lymphoblastic leukemia
    Barba, Pere
    Luis Dapena, Jose
    Montesinos, Pau
    Rives, Susana
    MEDICINA CLINICA, 2017, 148 (05): : 225 - 231
  • [45] Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
    Rank, Cecilie U.
    Lynggaard, Line Stensig
    Als-Nielsen, Bodil
    Stock, Wendy
    To, Nina
    Nielsen, Ove Juul
    Frandsen, Thomas Leth
    Tuckuviene, Ruta
    Schmiegelow, Kjeld
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (10):
  • [46] Safety of L-Asparaginase in a Child Cohort with Acute Lymphoblastic Leukaemia
    Sole, E.
    Maura, G.
    Sztejnman, H.
    Burde, F.
    Trenque, T.
    DRUG SAFETY, 2012, 35 (10) : 946 - 946
  • [47] Diabetic ketoacidosis secondary to L-asparaginase in acute lymphoblastic leukaemia
    Gifford, G.
    Milliken, S.
    Greenfield, J.
    INTERNAL MEDICINE JOURNAL, 2013, 43 (08) : 946 - 948
  • [48] Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group
    Salzer, Wanda L.
    Asselin, Barbara
    Supko, Jeffrey G.
    Devidas, Meenakshi
    Kaiser, Nicole A.
    Plourde, Paul
    Winick, Naomi J.
    Reaman, Gregory H.
    Raetz, Elizabeth
    Carroll, William L.
    Hunger, Stephen P.
    BLOOD, 2013, 122 (04) : 507 - 514
  • [49] Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol
    Raja, Raheel A.
    Schmiegelow, Kjeld
    Albertsen, Birgitte K.
    Prunsild, Kaie
    Zeller, Bernward
    Vaitkeviciene, Goda
    Abrahamsson, Jonas
    Heyman, Mats
    Taskinen, Mervi
    Harila-Saari, Arja
    Kanerva, Jukka
    Frandsen, Thomas L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (01) : 126 - 133
  • [50] PEG-asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta-analysis
    Lynggaard, Line Stensig
    Rank, Cecilie U.
    Als-Nielsen, Bodil
    Hoejfeldt, Sofie G.
    Heyman, Mats
    Schmiegelow, Kjeld
    Albertsen, Birgitte K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (05):
12345